Raffanti SR, Fusco JS, Becker SL, Sherrill BH, Hansen NI, Justice AC, D’Aquila R, Mangialardi WJ, Fusco GP. Effect of persistent viremia on disease progression during HIV therapy. Oral presentation. 4th Annual Observational Database Meeting. 2003, Washington D.C
Research Category: Oral Presentations
Metabolic syndrome
Fusco J, Wesolowski L, Becker S, Balu R, Fusco G. Metabolic syndrome. Oral presentation. 3rd Annual North American HIV Cohorts Meeting. Nov 2002, Washington D.C;.
Virologic Response to HAART
McKinnon E, Fusco J, John M, Fusco G, Becker S, James I, Mallal S. Virologic Response to HAART. Oral presentation. 3rd Annual North American HIV Cohorts Meeting. Nov, 2002, Washington D.C
HIV survival: liver function tests independently predict survival
Justice AC, Wagner JH, Fusco GP, Fusco JS, Dieterich DT, Becker SL, McGinnis KA, Conigliaro J, Bonomo R, and Rodriguez-Barradas M. HIV survival: liver function tests independently predict survival. Oral presentation. 1058. XIV International AIDS Conference. July 2002, Barcelona, Spain
The effect of treatment Interruption in patients with virologic failure: results from a multi-cohort collaborative study
Sabin C, Phillips A, Fusco J, Youle M, Gill J, Barbour J, D’Arminio Monforte A, Dauer B, Staszewski S, Braun J, Deeks S, Miller V. The effect of treatment Interruption in patients with virologic failure: results from a multi-cohort collaborative study. Oral presentation. 8th Conference on Retroviruses and Opportunistic Infections. Feb 2001, Chicago, IL
Treatment interruptions
Braun JF, Fusco JS. Treatment interruptions. Oral presentation. 2nd Annual North American HIV Cohorts Meeting, Dec 2000, Washington D.C
A markov model of long-term HIV/AIDS survival in the post-HAART era
King J, Justice AC, Chang J, Roberts M, Fusco JS, West N. A markov model of long-term HIV/AIDS survival in the post-HAART era. Oral presentation. 39th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Oct1999, San Francisco, CA
Extrapolating longterm HIV/AIDS survival in the post HAART era
Justice AC, Chang CH, Fusco JS, West N. Extrapolating longterm HIV/AIDS survival in the post HAART era. Oral presentation. 39th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Oct1999, San Francisco, CA
Nucleoside reverse transcriptase inhibitor sequencing—prior d4T therapy impairs viral load response to ZDV-containing regimens to a greater extent than ZDV prior to d4T
Becker S, Fusco G, Hansen N, Fusco J, Wilson D, Graham, N, Igboko E. Nucleoside reverse transcriptase inhibitor sequencing—prior d4T therapy impairs viral load response to ZDV-containing regimens to a greater extent than ZDV prior to d4T. Oral presentation. International Workshop on Salvage Therapy for HIV infection, May 1999, Toronto, Canada